$AZZ

AZZ Inc. raised its fiscal year guidance, expecting sales of $1.8B-$1.85B, adjusted EBITDA of $375M-$415M, and adjusted diluted EPS of $6.75-$7.15. The company cited demand in grid modernization, data centers, and infrastructure as growth drivers. AZZ also announced debt reduction and capital investments, including a new coil-coating plant and expanded galvanizing capacity. According to the company, it plans to continue organic growth, acquisitions, and shareholder returns.

Stovall Bryan Lee (COO - Metal Coatings) sold 2,677 shares of AZZ INC (AZZ) at $150.07 ($0.40M total) on 2026-08-14.

Vellines Jeffrey (Pres & COO - Precoat Metals) sold 4,220 shares of AZZ INC (AZZ) at $153.55 ($0.65M total) on 2026-08-11.

AZZ INC (AZZ) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. AZZ Inc. Announces the Appointment of Rhonda Davenport as Chief Human Resources Officer Veteran HR executive brings more than 20 years of leadership experience in culture transformation, talent development and organizational growth August 3, 2026 – FORT WORTH, TX - AZZ Inc. (NYSE

AZZ Inc. (NYSE: AZZ) said it acquired 100% of Seattle Galvanizing Company Inc., a privately held hot-dip and spin galvanizing provider in Arlington, Washington. Terms were not disclosed. AZZ expects the deal to be accretive to earnings in the first year and will add the sites to its Metal Coatings network, raising galvanizing sites to 43.

Argus published an AZZ Inc. stock forecast on Jul 29, 2026, lowering its target price to $163. AZZ Inc. provides galvanizing and metal coating solutions, including coil coating, for end markets in North America. The update matters for traders tracking analyst target changes for AZZ shares.

AZZ Inc’s Q1 2027 earnings call covered demand for electrical infrastructure and data centers despite interest rates and energy cost fluctuations. Management discussed its deverticalization model, active M&A pursuit, tariff and substrate supply constraints, and progress toward full capacity at the Washington, Missouri facility. Investors may track deal timing and capacity ramp.

Premarket movers included AstraZeneca, down 8% after its heart disease drug Wainua missed a late-stage trial target. PepsiCo fell 1% after Q2 adjusted EPS of $2.20 missed $2.21 consensus, while revenue beat. Salesforce and Stellantis slid on downgrades. Levi dropped on weaker Q3 guidance. AZZ rose on earnings and revenue beats; Cerebras gained on European expansion; Costco fell on slower June comps.

U.S. stock index futures rose after a mixed prior session, amid renewed U.S.-Iran tensions and Treasury yields at 4.56% (10-year) and 4.19% (2-year). CME FedWatch showed a 72.7% chance the Fed holds rates in July. Company moves: LEVI fell premarket despite Q2 results and FY2026 guidance; AZZ rose on record sales and FY2027 guidance; IONS dropped after a Phase 3 missed endpoint; WDFC was flat ahead of earnings.

AZZ (NYSE:AZZ) reported Q2 CY2026 revenue of $448.5 million, up 6.3% year on year, exceeding market expectations. Full-year revenue guidance midpoint is $1.83 billion, 4.3% above analysts’ estimates. Non-GAAP profit was $1.85 per share, 9.6% above consensus. The stock rose about 7.4% to $154.18 after results.